Look for:

Our offer for

WUXI BIOLOGICS (CAYMAN) INC.


ISIN:
KYG970081173
WKN:
-

2024/05/09 16:30:02
Price
1.7284 EUR
Difference 1.86% (0.03)

General attributes

ISINKYG970081173
Symbol2269
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,393 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.6074 EUR (9,600)
Ask (Ask size)1.8552 EUR (8,250)
Open1.7364 EUR
High1.7378 EUR
Low1.7284 EUR
Close (prev. day)1.6968 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades5
Last size0

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/04/26 en Global Equity Ratings PDF Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download


2024/05/09 16:30:02
Price
1.7284 EUR
Difference 1.86% (0.03)

General attributes

ISINKYG970081173
Symbol2269
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,393 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.6074 EUR (9,600)
Ask (Ask size)1.8552 EUR (8,250)
Open1.7364 EUR
High1.7378 EUR
Low1.7284 EUR
Close (prev. day)1.6968 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades5
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-72.34%-68.58%-84.57%
Perf (abs.)-4.44-3.70-9.30
Beta0.931.040.66
Volatility86.3971.4370.00
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.7309 EUR (600)
Ø price 30 days | Ø volume 30 days (pcs.)1.6455 EUR (110)
Ø price 100 days | Ø volume 100 days (pcs.)2.3364 EUR (33)
Ø price 250 days | Ø volume 250 days (pcs.)3.9985 EUR (14)
YTD High | date3.6020 EUR (2024/01/16)
YTD Low | date1.5128 EUR (2024/04/25)
52 Weeks High | date6.1400 EUR (2023/11/08)
52 Weeks Low | date1.5128 EUR (2024/04/25)

All listings for WUXI BIOLOGICS (CAYMAN) INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/05/0909:301.7132 EUR0.001
Stuttgart2024/05/0908:051.7072 EUR0.001
Munich2024/05/0908:041.7168 EUR0.001
Hong Kong Stock Exchange2024/05/0910:0814.58 HKD--
Frankfurt2024/05/0908:051.7106 EUR0.001
FINRA other OTC Issues2024/05/0120:121.63 USD0.001
Duesseldorf2024/05/0916:301.692 EUR0.004
Berlin2024/05/0916:301.7284 EUR0.005

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=143050&ID_TYPE_IMAGE_LOGO=2

Contact Details

WUXI BIOLOGICS (CAYMAN) INC.
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Members of Management Board

Zhisheng (Chris) Chen, Ph.D.Chairman of Managing Board
Christine Lu-WongMember of Executive Committee
Jijie Gu, Ph.D.Member of Executive Committee
Weichang Zhou, Ph.D.Member of Executive Committee

Board of directors

Ge LiChairman of Supervisory Board
Jue ChenMember of Supervisory Board
Weichang ZhouMember of Supervisory Board
Yi Bing WuMember of Supervisory Board
Jackson TaiMember of Supervisory Board
Kenneth HitchnerMember of Supervisory Board
William KellerMember of Supervisory Board
Yan Ling CaoMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer